drugset / Trial / NCT00840632

Trandolapril 4 mg Tablet Under Fasting Conditions

NCT00840632

Phase 1 Completed 40 enrolled Teva Pharmaceuticals USA
RandomizedCrossoverOpen-labelOther

Summary

The objective of this study is to compare the rate and extent of absorption of trandolapril from a test formulation of Trandolapril 4 mg Tablets versus the reference Mavik® 4 mg Tablets under fasting conditions.

Timeline

Start
2004-10
Primary completion
2004-11
Completion
2004-11

Drugs

EvaluationDrugModalityDoseRoute
Subject trandolapril Small molecule 4 mg

Indications

No indication recorded.